BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
Approval of BEXSERO is based on immune response against three group B bacterial strains representative of prevalent strains in the US. Effectiveness against various other group B strains has not been confirmed.
BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
Approval of BEXSERO is based on immune response against three group B bacterial strains representative of prevalent strains in the US. Effectiveness against various other group B strains has not been confirmed.
BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.
Approval of BEXSERO is based on immune response against three group B bacterial strains representative of prevalent strains in the US. Effectiveness against various other group B strains has not been confirmed.
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions
- Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding
- Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
- The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions
- Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding
- Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
- The most common side effects are pain, redness or hardness at the injection site; muscle pain; fatigue; headache; nausea; and joint pain
- Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
- Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
- Vaccination with BEXSERO may not result in protection in all vaccine recipients
- Ask your healthcare provider about the risks and benefits of BEXSERO. Only a healthcare provider can decide if BEXSERO is right for you or your child
